Snake bite management in a toddler: a case report in Sumbawa Besar
Abstract
Snake bite is an often-neglected,1 life-threatening emergency prevalent in rural areas of tropical countries such as Indonesia.2 The WHO reported a worldwide incidence of 5 million snake bites per year, with 100,000–200,000 deaths.3 The incidence rate and likelihood of subsequent complications are higher in children than adults.4 According to the WHO, 35% of child deaths related to poisonous animal bites are attributable to snake bites and occur more frequently in boys than girls.5 In Indonesia, no national epidemiological data on snake bites in children is available, but the WHO estimated that 5–8 snake bite cases occur weekly in Lombok, West Nusa Tenggara.6
Lower limbs are the most common site for bites (72%), while facial bites are quite rare (10%).7 Bites involving children and/or the face are considered as severe envenomation and usually require antivenom at an appropriate dose and timing to be effective.8 Therefore, it is important that hospitals are equipped with life-saving intervention measures to optimize care and improve the chances of survival.9 Nevertheless, in developing countries, the use of antivenom is limited by the absence of standardized guidelines, scarcity/unavailability, and high cost.9 In Indonesia, the only antivenom, serum antibisa ular (SABU), is costly and difficult to obtain due to limited quantities, especially in rural areas. Furthermore, SABU is a polyvalent antivenom with low coverage, as it is only indicated for Naja sputatrix, Bungarus fasciatus, and Agkistrodon rhodostoma, despite the numerous other snake species endemic to Indonesia.2
References
2. Warrel DA. Snake bite. Lancet. 2010;375:77–88. DOI: 10.1016/S0140-6736(09)61754-2.
3. World Health Organization. World report on child injury prevention. 1st ed. Geneva: World Health Organization; 2008. p. 123–38.
4. Niasari N, Latief A. Gigitan ular berbisa. Sari Pediatri. 2003;5:92–8. DOI: 10.14238/sp5.3.2003.92-8
5. Chippaux JP. Snake-bites: appraisal of the global situation. Bull World Health Organ. 1998;76:515–24. Available from: https://apps.who.int/iris/handle/10665/56029.
6. WHO Guidelines for the management of snakebites. 2nd ed. Geneva: World Health Organization; 2016. p. 75–104.
7. Cavazos MEDO, Garza CT, Guajardo-Rodríguez G, Hernández-Montelongo BA, Montes-Tapia FF. Snake bites in pediatric patients, a current view. In: Özdemir Ö, editor. Complementary pediatrics. 1st ed. Croatia: Intech; 2012. p. 123–36.
8. Habib AG. Public health aspects of snakebite care in West Africa: perspectives from Nigeria. J Venom Anim Toxins Incl Trop Dis. 2013;19:27. DOI: 10.1186/1678-9199-19-27
9. Ahmed SM, Ahmed M, Nadeem A, Mahajan J, Choudhary A, Pal J. Emergency treatment of a snake bite: pearls from literature. J Emerg Trauma Shock. 2008;1:97–105. DOI: 10.4103/0974-2700.43190
10. Silva A, Marikar F, Murugananthan A, Agampodi S. Awareness and perceptions on prevention, first aid and treatment of snakebites among Sri Lankan farmers: a knowledge practice mismatch? J Occup Med Toxicol. 2014;9:20. DOI: 10.1186/1745-6673-9-20
11. Adiwinata R, Nelwan EJ. Snakebite in Indonesia. Acta Med Indones. 2015;47(4):358–65. Available from: http://www.actamedindones.org/index.php/ijim/article/view/30/28
12. Chippaux JP, Rage-Andrieux V, Le Mener-Delore V, Charrondiere M, Sagot P, Lang J. Epidemiology of snake envenomations in northern Cameroon. Bull Soc Pathol Exot. 2002;95:184–7. PMID: 12404867
13. Kreisfeld R, Winkel KD, Harrison J. Hospitalisations due to animal and plant injury in Australia 2000/01–2001/2. 1st ed. Canberra: Research Centre for Injury Studies, Australian Institute of Health and Welfare; 2007. p. 123–42.
14. Micheal GC, Aliyu I, Grema BA. Viper bite on the neck following a fight. Sudan Med Monit. 2015;10:133–6. DOI: 10.4103/1858-5000.171865
15. Fatima LD, Fatah C. Pathophysiological and pharmacological effects of snake venom components: molecular targets. J Clin Toxicol. 2014;4:1–9. DOI: 10.4172/2161-0495.190
16. Juckett G, Hancox JG. Venomous snakebites in the United States: management review and update. Am Fam Physician. 2002;65:1367–74. PMID: 11996419
17. Ledsgaard L, Jenkins TP, Davidsen K, Krause KE, Martos-Esteban, Engmark M, et al. Antibody cross-reactivity in antivenom research. Toxins. 2018;10:393. DOI: 10.3390/toxins10100393.
18. World Health Organization. Snakebite envenoming. [Internet]. [cited 2019 December 07] Available from: https://www.who.int/snakebites/treatment/en/.
19. Wangoda R, Warmon B, Kisige M. Snakebite management: experiences from Gulu Regional Hospital Uganda. East Cent Afr J Surg. 2004;9:82–6. Available from: https://www.ajol.info/index.php/ecajs/article/view/137289.
Copyright (c) 2021 Ferry Liwang
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Accepted 2021-07-29
Published 2021-07-29
